Back to Authors

Armaghany, Tannaz

https://orcid.org/0000-0002-8588-0056

A5073278376

Mayo Clinic

Westchase Oncology Center, Houston, TX;

Citations 1

A phase I/II study of TKM-080301, a PLK1-targeted RNAi in patients with adrenocortical cancer (ACC).

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2547-2547

10.1200/jco.2016.34.15_suppl.2547